During the past decade, UNC Medical Center, Dept. of Rheumatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Medical Center, Dept. of Rheumatology" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 2 trials as a collaborator and "Office of Research on Women's Health (ORWH)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UNC Medical Center, Dept. of Rheumatology" are "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "UNC Medical Center, Dept. of Rheumatology" in a lesser frequency.

Most popular intervention types in "UNC Medical Center, Dept. of Rheumatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ortho-Novum 777" (1 trials) and "Premarin and Provera" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Medical Center, Dept. of Rheumatology" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "UNC Medical Center, Dept. of Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UNC Medical Center, Dept. of Rheumatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UNC Medical Center, Dept. of Rheumatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".